![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » NOVARTIS GETS HEALTH CANADA APPROVAL FOR FEMARA TO TREAT BREAST CANCER
NOVARTIS GETS HEALTH CANADA APPROVAL FOR FEMARA TO TREAT BREAST CANCER
Novartis Pharmaceuticals Canada announced the Health Canada approval of Femara, or letrozole, as adjuvant (post-surgery) treatment for postmenopausal women with hormone receptor-positive early breast cancer. Trading Markets (http://www.tradingmarkets.com/.site/news/BREAKING%20NEWS/449422/)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct